Treatment with PDE4 inhibitors also induces hyperglycemia; however, several lines of evidence suggest that the glycemic effects of PDE4 inhibitors are not predominantly driven by changes in either insulin secretion or signaling. The gene discussed is PDE4A; the disease is Hyperglycemia.